Article
An integrated multimodal model for early prediction of high-risk recurrence phenotype indicative of poor disease-free survival in stage IA NSCLC: a multicenter study.
Frontiers in immunology - 1 Jan 2026
Lai Linqiang, Wang Yanji, Jiang Jiangle, Yang Dengfa, Wu Jinying, Xie Liangjun, Wu Jiahao, Mao Ruolan, Zhang Dengke, Wang Xiangxue, Ming Wenlong, Tu Jianfei
Abstract excerpt
Objectives: To develop and validate a preoperative multimodal model that predicts a high-risk recurrence phenotype indicative of poor disease-free survival (DFS), in order to stratify patients with stage IA non-small cell lung cancer (NSCLC). Materials and methods: This retrospective multicenter study enrolled 342 stage IA NSCLC patients from three independent centers. The high-risk recurrence phenotype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
